Chapter 432 - 260: Milestone! Fengmu Tiada’s Clinical Debut
Chapter 432: Chapter 260: Milestone! Fengmu Tiada’s Clinical Debut
Zhang Heng and his team had spent a long time in special training for the transarterial chemoembolization procedure, all in preparation for today’s demonstration.
With the aid of the 3D image guidance system, Zhang Heng was in charge of the entire procedure while Wu Ting, as the team leader, supervised from the side.
This was the agreement Wu Ting and Zhang Heng had made beforehand!
Zhang Heng stood at the operating table. Despite having gone through thousands of practice sessions, the thought of all the VIPs in the observation room and the experts and professors across the country watching the live stream still made him genuinely excited and nervous.
He had never expected Wu Ting to give him such a major opportunity to take the spotlight.
This was a groundbreaking surgery, a milestone in the development of a radical cure for hepatitis B-related primary liver cancer.
If their research project was ultimately successful, he, Zhang Heng, would go down in medical history right alongside Wu Ting. Their names would even be printed in medical textbooks.
Zhang Heng felt truly fortunate to have followed Wu Ting in his research. He had listened to his advice, completely abandoned his previous, misguided path, and now walked a golden road toward both fame and fortune.
Before he began, Zhang Heng offered a quiet word of thanks. "Thank you for this opportunity, Director Wu!"
Zhang Heng himself was not lacking in aptitude or talent. Having focused on this one project for so long—like sharpening a sword for ten years—he displayed an exceptional level of skill the moment he began!
He began with a puncture using the Seldinger Technique... After thousands of drills, every single step had been optimized and refined.
A perfect puncture on the first attempt!
Next came the insertion of an ultra-smooth guidewire, the injection of the contrast agent, and the positioning of the target vessel...
As Zhang Heng operated, everyone could see the 3D imaging system on the side screen, tracking and recording in real time. Since this was the debut of Phase Three and there was no precedent, the system was currently only in recording mode.
It was clear that once the surgical volume increased, Phase Three would lead to the development of various optimal surgical plans, just as Phase Two had.
At the operating table, Zhang Heng repeated the steps he had performed thousands of times, the movements long since committed to muscle memory.
The core innovation in this embolization therapy was the first-ever use of the new drug, Fengmu Tiada!
Gelatin sponge particles of various lengths were loaded into a syringe and injected under fluoroscopic guidance, occluding the artery...
The entire procedure was so smooth and deft that even Wu Ting found himself captivated watching it.
’I have to admit, Zhang Heng has really poured his heart and soul into his work these days!’
In the observation room, the directors were equally impressed and full of admiration. They had thought Wu Ting was the only star in City First Hospital’s Hepatic Tumor Surgery department, but it turned out this Director Zhang Heng was also exceptionally skilled.
Director Ma of Hepatic Tumor Surgery at Jin Province Tumor Hospital, Zhang Heng’s old director, watched the surgery with a mix of emotion and happiness for his former subordinate. ’Zhang Heng is a rare talent,’ he thought.
’He really found the right path and the right person to follow. Just being a key participant in this single surgery is enough to guarantee his fame and success!’
’And being able to train Zhang Heng to be so disciplined and loyal only further demonstrates Wu Ting’s own extraordinary talent and charisma.’
On the operating table, Zhang Heng recalled the first time he had discussed this procedure with Wu Ting. Back then, Wu Ting had given him eight points of criticism on the spot!
Now, things were different. Zhang Heng smiled inwardly. He had polished this procedure through countless repetitions until it was absolutely flawless!
Guo Guoguo, who was assisting nearby, was also overcome with emotion. She felt happy and proud for herself, and for Director Zhang.
’These days, all I feel is the pride and honor of being on Director Wu’s team,’ she thought. ’Who’d still think of this place as a stepping stone? They couldn’t chase me away even if they tried.’
’If you follow Director Wu, you’ll have money, you’ll have prestige, and you’ll definitely have a future!’
The surgery was completed quickly.
In the observation room, all the directors were left wanting more!
The patient’s key metrics had improved significantly over the course of the operation. Now, all they needed to do was wait for the post-operative data.
For now, at least, the patient’s surgery was a perfect success!
After the surgery, Jia Jun of Wu Ting’s team came out once more to announce the various data points and metrics for Fengmu Tiada from the preclinical trials.
He also presented the projections and evaluations for Fengmu Tiada following its human clinical trials.
"Over the next treatment cycle, our team will publicly release the patient’s serum ALT, TBIL, AFP, and HBV DNA levels daily..."
"Fengmu Tiada, as an original drug from our Wu’s Pharmaceutical Company, has been proven effective in improving HBV DNA, AFP, liver function, and immune function... Within one cycle, it will dramatically improve the patient’s condition. Once they are stabilized, we can proceed with our Phase Two combination therapy—immunonegative regulation therapy combined with tumor resection—to complete the radical cure."
After Jia Jun’s speech, all the experts in attendance prepared to closely monitor Professor Long’s subsequent recovery.
And indeed, events unfolded just as Jia Jun had predicted.
Professor Long’s various metrics were published daily on the official website of Wu’s Pharmaceutical Company and the webpage for City First Hospital’s Hepatic Tumor Surgery department.
Her metrics showed significant improvement. By the fifteenth day, they had dropped to the target levels!
After a month of stabilization, Professor Long underwent the Phase Two tumor resection surgery!
The surgery was a complete success.
In other words, as long as Professor Long did not relapse during the follow-up period, it meant that Wu Ting’s team had radically cured her mid-to-late-stage, hepatitis B-related primary liver cancer—a condition deemed absolutely incurable by every existing treatment plan in the medical system!
After compiling all the data from the treatment process, Zhang Heng’s team drafted a report. They integrated information on Professor Long’s current quality of life, compiled everything into a single file, and sent it to their collaborating experts and professors.
That evening, Dean Chen gathered Director Fu, Director Ma, Director Jin, and others. They traveled to Qinghe City to find Scholar Zeng and discuss a truly major event in the field of radical cures for hepatitis B-related primary liver cancer!
...
...
While Zhang Heng’s team continued to follow up on Professor Long’s prognosis, Wu Ting threw all his energy into research for the controllable, adjustable, self-expanding valve delivery system project, where progress was also moving at lightning speed!